Zdrowie i gospodarka · 21/08/2026

FDA Renewal of Oncologic Drugs Advisory Committee

The Food and Drug Administration (FDA) is renewing the Oncologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on September 1, 2028, following a determination by the Commissioner of Food and Drugs that it is in the public interest.